RI-STAD 2

• Description :

  AKAP disruptor. Selectively binds PKA-RI with high affinity (KD values are 6.2 and 12.1 nM for the RIα and β subunits, respectively) and blocks its interaction with AKAP. Inhibits type I PKA-mediated phosphorylation in live cells. Cell permeable.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  2401.75

• Molecular Formula :

  C109H181N25O35

• Notes :

  Research use only, not for human use.

• Receptor :

  ——